Literature DB >> 25377315

Glucose-dependent insulinotropic polypeptide-mediated signaling pathways enhance apical PepT1 expression in intestinal epithelial cells.

Steven D Coon1, Vazhaikkurichi M Rajendran2, John H Schwartz3, Satish K Singh4.   

Abstract

We have shown recently that glucose-dependent insulinotropic polypeptide (GIP), but not glucagon-like peptide 1 (GLP-1) augments H(+) peptide cotransporter (PepT1)-mediated peptide absorption in murine jejunum. While we observed that inhibiting cAMP production decreased this augmentation of PepT1 activity by GIP, it was unclear whether PKA and/or other regulators of cAMP signaling pathway(s) were involved. This study utilized tritiated glycyl-sarcosine [(3)H-glycyl-sarcosine (Gly-Sar), a relatively nonhydrolyzable dipeptide] uptake to measure PepT1 activity in CDX2-transfected IEC-6 (IEC-6/CDX2) cells, an absorptive intestinal epithelial cell model. Similar to our earlier observations with mouse jejunum, GIP but not GLP-1 augmented Gly-Sar uptake (control vs. +GIP: 154 ± 22 vs. 454 ± 39 pmol/mg protein; P < 0.001) in IEC-6/CDX2 cells. Rp-cAMP (a PKA inhibitor) and wortmannin [phosophoinositide-3-kinase (PI3K) inhibitor] pretreatment completely blocked, whereas neither calphostin C (a potent PKC inhibitor) nor BAPTA (an intracellular Ca(2+) chelator) pretreatment affected the GIP-augmented Gly-Sar uptake in IEC-6/CDX2 cells. The downstream metabolites Epac (control vs. Epac agonist: 287 ± 22 vs. 711 ± 80 pmol/mg protein) and AKT (control vs. AKT inhibitor: 720 ± 50 vs. 75 ± 19 pmol/mg protein) were shown to be involved in GIP-augmented PepT1 activity as well. Western blot analyses revealed that both GIP and Epac agonist pretreatment enhance the PepT1 expression on the apical membranes, which is completely blocked by wortmannin in IEC-6/CDX2 cells. These observations demonstrate that both cAMP and PI3K signaling pathways augment GIP-induced peptide uptake through Epac and AKT-mediated pathways in intestinal epithelial cells, respectively. In addition, these observations also indicate that both Epac and AKT-mediated signaling pathways increase apical membrane expression of PepT1 in intestinal absorptive epithelial cells.

Entities:  

Keywords:  CDX2 expression; IEC-6 cells; Intestinal absorptive epithelial cells; dipeptide uptake Gly-Sar uptake.

Mesh:

Substances:

Year:  2014        PMID: 25377315      PMCID: PMC4281688          DOI: 10.1152/ajpgi.00168.2014

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  65 in total

1.  Estrogen potentiates prostaglandin E₂-stimulated duodenal mucosal HCO₃⁻ secretion in mice.

Authors:  Biguang Tuo; Guorong Wen; Xue Wang; Jingyu Xu; Rui Xie; Xuemei Liu; Hui Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-04-24       Impact factor: 4.310

Review 2.  Dietary effects on incretin hormone secretion.

Authors:  Tongzhi Wu; Christopher K Rayner; Karen Jones; Michael Horowitz
Journal:  Vitam Horm       Date:  2010       Impact factor: 3.421

3.  PKCδ-dependent activation of ERK1/2 leads to upregulation of the human NHE2 transcriptional activity in intestinal epithelial cell line C2BBe1.

Authors:  Saminathan Muthusamy; Sagar Shukla; Md Ruhul Amin; Ming Cheng; Temitope Orenuga; Pradeep K Dudeja; Jaleh Malakooti
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-03       Impact factor: 4.052

4.  Glucose-dependent insulinotropic polypeptide regulates dipeptide absorption in mouse jejunum.

Authors:  Steven D Coon; John H Schwartz; Vazhaikkurichi M Rajendran; Lisa Jepeal; Satish K Singh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-09-26       Impact factor: 4.052

5.  PI3 kinase and PDK1 in the regulation of the electrogenic intestinal dipeptide transport.

Authors:  Rexhep Rexhepaj; Anand Rotte; Venkanna Pasham; Shuchen Gu; Daniela S Kempe; Florian Lang
Journal:  Cell Physiol Biochem       Date:  2010-05-18

6.  beta-Adrenergic activation of electrogenic K+ and Cl- secretion in guinea pig distal colonic epithelium proceeds via separate cAMP signaling pathways.

Authors:  Susan T Halm; Jin Zhang; Dan R Halm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-22       Impact factor: 4.052

7.  Regulation of renal tubular glucose reabsorption by Akt2/PKBβ.

Authors:  Daniela S Kempe; Gulab Siraskar; Henning Fröhlich; Anja T Umbach; Michael Stübs; Florian Weiss; Teresa F Ackermann; Harald Völkl; Morris J Birnbaum; David Pearce; Michael Föller; Florian Lang
Journal:  Am J Physiol Renal Physiol       Date:  2010-02-17

Review 8.  Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease.

Authors:  Siamak A Adibi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-11       Impact factor: 4.052

9.  Intestinal sugar absorption is regulated by phosphorylation and turnover of protein kinase C betaII mediated by phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent pathways.

Authors:  Philip A Helliwell; Martin G Rumsby; George L Kellett
Journal:  J Biol Chem       Date:  2003-05-22       Impact factor: 5.157

Review 10.  Gastrointestinal hormones and the regulation of β-cell mass.

Authors:  Jeremy A Lavine; Alan D Attie
Journal:  Ann N Y Acad Sci       Date:  2010-10-29       Impact factor: 5.691

View more
  3 in total

Review 1.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

2.  Functional intercalated nanocomposites with chitosan-glutathione-glycylsarcosine and layered double hydroxides for topical ocular drug delivery.

Authors:  Tingting Xu; Xiaoyue Xu; Yan Gu; Lei Fang; Feng Cao
Journal:  Int J Nanomedicine       Date:  2018-02-13

3.  Slc15a1 is involved in the transport of synthetic F5-peptide into the seminiferous epithelium in adult rat testes.

Authors:  Linlin Su; Yufei Zhang; Yan C Cheng; Will M Lee; Keping Ye; Dahai Hu
Journal:  Sci Rep       Date:  2015-11-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.